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Texas  75235) 
Murine  B  cells  from bone  marrow  (1)  and  neonatal  spleen  (2,  3)  are  more 
readily tolerized than splenic B cells from adults. The maturational decrease in 
susceptibility  to  tolerance  induction  is  accompanied  by  the  acquisition  of a 
variety  of surface molecules  including IgD  (4),  Lyb3  (5),  MLS  (6),  and the C' 
receptor  (7).  In  addition,  mature  B  cells,  in  contrast  to  immature  ones,  can 
replace surface Ig molecules which have been removed by treating the cells for 
prolonged periods of time with divalent antibody to Ig,  antigen,  or proteolytic 
enzymes  (8, 9). 
We have previously hypothesized that the decreased susceptibility of mature 
B cells to induction of tolerance may be a result of the acquisition of surface IgD 
(2).  To test this possibility,  IgD has been removed from mature B  cells under 
conditions  in  which  a  variety  of other  surface  markers  remain  intact.  The 
susceptibility  of these altered cells to in vitro induction of tolerance has been 
examined. The results suggest that there is a direct correlation between the loss 
of surface  IgD  from  mature  cells  and  an  increase  in  susceptibility  to  the 
induction of tolerance. 
Materials  and  Methods 
Animals.  BDF~ (C57BL/6 female  ×  DBA/2  male F~) and A/J mice, 8- to 10-wk of age  (The 
Jackson Laboratory, Bar Harbor, Maine) were used in this study. Animals to be used as the source 
of helper T  cells were carrier-primed by  intravenous injection of sheep erythrocytes  (SRBC) ~ 
(Colorado  Serum Co.,  Denver,  Colo.;  0.2  ml of 0.01% suspension)  7 days  before sacrifice (10). 
Spleen cell suspensions from primed animals were irradiated (1500 R; ~ZTcesium source) to remove 
B-cell activity before cultivation. 
Antigens.  Human gamma globulin (Cohn  fraction II, Sigma Chemical Co.,  St.  Louis, Mo.) 
was  haptenated  by using 2,  4,  6,  trinitrobenzene sulfonic acid (TNBS,  J.  T.  Baker Chemical 
* Supported  by  National Institutes of Health grants  AI-11851, AI-10967, AI-12789,  and  AI- 
11893. 
Supported by postdoctoral grant no. AI-05021-01. 
1Abbreviations  used  in  this paper:  BSS,  balanced salt  solution; CR,  complement receptor; 
CRL,  complement  receptor-bearing  lymphocytes;  GARIg,  goat  anti-rabbit  Ig;  GVB,  gelatin 
veronal buffer; HRBC, horse erythrocytes; PBS, phosphate-buffered saline; PFC, plaque-forming 
cells; RAMIg, rabbit anti-mouse Ig; SDS, sodium dodecyl sulfate; SDS-PAGE, SDS polyacrylamide 
gels; SRBC, sheep erythrocytes; TCA, trichloracetic acid; TD, thymus dependent; TI, thymus in- 
dependent; TNBS, trinitrobenzene sulfonic acid; TNP, trinitrophenyl. 
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Co.,  Phillipsburg,  N.  J.)  to  a  substitution  ratio  of  17:1  (TNPITHgG)  (10,  11)  as  determined 
spectrophotometrically.  Heat  killed  BruceUa  abortus  (National  Animal  Disease  Laboratory, 
Ames, Iowa) (12) and SRBC (13) were haptenated as previously described. 
Induction of Unresponsiveness.  TNP-specific unresponsiveness was induced as described pre- 
viously  (2).  Briefly,  normal or papain-treated mouse spleen cells were incubated for 24 h  at a 
density of 107/ml in the presence of graded concentrations of TNP17HgG. Cells were then washed 3 
times and resuspended at a density of 10  v cells/ml in complete medium and plated in 35-mm Falcon 
dishes,  (Falcon Plastics,  Div.  of BioQuest,  Oxnard,  Calif.) 0.5 ml per dish.  To each dish were 
added, 8  ×  106 irradiated SRBC primed spleen cells in 0.1 ml complete medium and either TNP- 
SRBC (0.1 ml of 0.1% suspension) or TNP-Brucella  (0.1 ml of 0.01% suspension) in balanced salt 
solution (BSS). 
Antigen doses were chosen on the basis of their capacity to stimulate optimal direct plaque- 
forming cell (PFC) responses in control experiments. TNP-SRBC and TNP-Brucella  were deter- 
mined  to  be thymus-dependent  (TD)  and thymus-independent  (TI),  respectively,  as  described 
elsewhere  (12).  During  the  immune  response  phase,  cultures  were  incubated  (14)  to  obtain 
primary PFC responses to TNP-SRBC.  The number of direct PFC was determined 4 days after 
immunogenic challenge. 
Assay.  PFC to SRBC were determined by a microscope slide modification (15) of the hemolysis 
in gel technique (16).  Anti-TNP PFC were determined by using TNP horse erythrocytes (HRBC) 
(17).  HRBC  (Colorado Serum Co.) -specific PFC were subtracted from TNP-HRBC  PFC to yield 
TNP-specific PFC.  Data points represent means of triplicate cultures pooled immediately before 
assay. 
Papain Digestion.  Mouse spleen cells were treated with papain (Sigma Chemical Co., 2 times 
recrystallized from papaya latex, 25 mg/ml) under conditions described previously (18). Cells were 
suspended  (107/ml) in minimal essential medium containing 10%  fetal calf serum and varying 
amounts of papain (0-150/~g/ml). Cysteine (final concentration 0.1 mM) was added to the suspen- 
sion and cells were incubated for 30 min at 37°C.  Control cells received cysteine alone. At the end 
of the incubation period cultures received iodoacetamide to a final concentration of 0.1 mM. Cells 
were then pelleted and washed 3 times in BSS. 
Preparation  and Analysis of Radioiodinated  Cells.  Splenocytes were iodinated as described 
previously (19).  After iodination, cells were suspended in complete medium and incubated for 20 
min at 37°C to remove remaining free 12sI. Cells were washed and in some instances treated with 
papain. After treatment, cells were lysed in 0.5% Nonidet P-40 (Shell Chemical Co., New York). 
Fetal calf serum was added to the lysates to a final concentration of 10%. Samples were dialyzed 
for 16 h against 1,000 vol of phosphate-buffered saline (PBS) at 4°C and centrifuged at 10,000g for 
30 min.  Protein-associated radioactivity was determined by precipitating a  small sample of the 
lysate in 5% trichloracetic acid (TCA) (20).  Portions of each sample were treated with saturating 
amounts  of rabbit anti-mouse  Ig  (RAMIg)  (21),  or  C57BL/6  anti-CBA  (anti-H-2  k,  Ia  k)  serum. 
Complexes  were  adsorbed  to  fixed  Staphylococcus  aureus.  (Cowans-I  strain)  (22),  pelleted, 
washed,  and antigen-antibody complexes eluted from the bacteria by boiling for 1-2 min in 1% 
sodium dodecyl sulfate  (SDS) containing 8 M  urea and 0.1  M  2-mercaptoethanol pH 8.6.  When 
anti-Lyb-2 serum  (23) was used,  lysates were first treated with RAMIg and goat anti-rabbit Ig 
(GARIg) (21) to remove surface Ig. The supernates were then treated with anti-Lyb-2 and goat anti- 
mouse Ig. Precipitates were dissolved in 1% SDS, 8 M urea. The eluates and dissolved precipitates 
were  electrophoresed for  16  h  at  4  mA/gel  on  7.5  SDS-polyacrylamide  gels  (SDS-PAGE)  (20). 
Internal  markers  consisting  of 3H-~  and  3H-L  (K)  chains  were  added  to  each  sample  before 
electrophoresis (24).  Gels were fractionated and counted by using a  Beckman LS350 counter with 
appropriate discriminators.  (Beckman Instruments, Inc., Cedar Grove, N. J.) 
Preparation  of the C57BL/6 Anti-CBA Serum.  C57BL/6 mice were injected intraperitoneally 
at weekly intervals for 7 mo with a mixture of spleen and lymph node cells from CBA/J mice. The 
mice were bled bimonthly and the pooled serum was assayed for its ability to bind H-2 and Ia 
molecules  from  lysates  of radioiodinated  splenocytes  from  a  variety  of mouse  strains.  These 
included CBA, C57BL/6, A/J, B10.HTT, B10.AQR, and B10.T(6R). The latter three strains were a 
gift from Dr. Jan Klein. Optimal amounts of the serum were added to dialyzed lysates and the im- 
mune complexes were adsorbed to killed S. aureus. The bound material was eluted and electro- 
phoresed as described above. The data presented in Fig.  1 indicate that the antiserum recognizes 
H-2K k, Ia  k, and Ic k molecules as assessed by both strain distribution and the molecular weight of CAMBIER,  VITETTA,  KETTMAN,  WETZEL,  AND  UHR 
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FIG.  l.  SDS-polyacrylamide electropherogram of cell membrane-associated proteins pre- 
cipitable with C57BL/6 anti-CBA serum. 
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the antigen. The serum does not contain anti-8 antibodies as described previously for this strain 
combination (25). 
Preparation  of Anti-Lyb-2.  Anti-Lyb-2 was the generous gift of Doctors E.  A.  Boyse,  J.-S. 
Tung, and F.  W. Shen, from the Sloan-Kettering Institute. The serum was raised in C3H.I mice 
against I/St ascites tumor 1.29 (H-2J).  As shown elsewhere, the serum recognizes a  molecule on B 
cells (22) which has an apparent mol wt of 44,000. 2 
Complement  Receptor-Bearing  Lymphocytes.  Complement  receptor-bearing  lymphocytes 
(CRL)  were  assayed  according  to  published  procedure  (26)  with  the  following  modifications. 
Sensitization of SRBCs was conducted in 0.01  M  EDTA-GVB (gelatin veronal buffer). Rosettes 
were formed by incubation of 2.5% erythrocyte antibody-complement complexes in 0.04 M EDTA- 
GVB with an equal volume of washed cells in PBS (3-6  ×  106 cells/ml). 
Assay of Chromium Release and [3H]Leucine Incorporation.  Chromium release from papain- 
treated or control cells was assayed as described by Wigzell (27).  CP 1 was obtained from Amer- 
sham/Searle Corp. Arlington Heights, Ill. Protein synthesis was analyzed by incubation of papain- 
treated and control cells for 24 h in complete medium containing [3H]leucine (Amersham/Searle). 
After incubation, cells were harvested, lysed, and precipitated with RAMIg and GARIg. Protein 
associated  radioactivity  was  determined  by precipitating  a small  sample of  the lysate  in  5% TCA. 
Precipitates  were washed, dissolved,  and counted in a Beckman LS350 counter. 
Results 
Removal of Cell  Surface  Molecules  by Papain.  Prior  studies  have  estab- 
lished that treatment of murine splenocytes with an appropriate concentration 
of papain results in cleavage of cell surface IgD with little or no removal of cell 
surface IgM (18).  In the following experiments, we have evaluated the effect of 
2  Tung, J.-S.,  E. S. Vitetta,  and E. A. Boyse. Manuscript in preparation. 110  B-CELL  TOLERANCE 
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FIG.  2.  SDS-polyacrylamide electropherograms of cell membrane-associated H-2 (A), Ia 
(A), IgM (B), IgD (B), and Lyb-2 (C) from normal-(-) and papain-(---)  treated splenocytes. 
such a  concentration of papain on several other cell surface markers to deter- 
mine if IgD is unusual in its susceptibility to cleavage by papain. 
As shown in Fig. 2 B, treatment of cells with 150/~g/ml papain resulted in the 
removal of approximately 90% of surface IgD as assessed by the loss of the 8- 
chain  peak on SDS-gels after electrophoresis of the dissolved immunoprecipi- 
tate. Under the same conditions, IgM, H-2, Ia, and Lyb-2 were not cleaved (Figs. 
2 A,  B, and C).  Table I  summarizes the results of similar experiments  which 
indicate that only IgD is cleaved by treatment of the cells with papain. In three 
experiments, the effect of papain on the complement receptor was studied. The 
mean percent CRLs among total splenic leukocytes in controls was 15 _+ 5.2 SD, 
while the mean in papain treated populations was 11 _+ 3.7. The difference is not 
statistically significant. 
Thus, among the six surface antigens studied (IgM, IgD, H-2, Ia, Lyb-2, and 
CR) only IgD was removed by papain under the conditions used in these experi- 
ments. 
Effect of  Papain on Cell Viability and Biosynthesis.  Treatment of cells with 
papain  could affect intracellular  functions in addition to altering  surface pro- 
teins. As shown in Table II, when cells treated with papain were labeled in vitro 
for 24 h with [~H]leucine, treated cells incorporated as much precursor into total 
protein and Ig as control cells. Moreover, Cr  51 release from treated and control 
cells was similar,  suggesting that  papain  treatment  affected neither  viability 
nor synthesis of protein. 
Effect of  Papain on Immune Responsiveness.  The effect of treating cells with 
papain on their subsequent immune responsiveness was studied as a necessary 
prelude to evaluating such treatment on induction of tolerance. Thus, cells were 
exposed to SRBC or TNP-Brucella  immediately  after treatment  with various 
combinations  of the  reagents  used  in  the  papain  digestion  procedure.  When 
SRBC were the antigen, cultures were supplemented with SRBC-primed irradi- 
ated splenocytes. Cultures were incubated for four days and direct anti-TNP and 
anti-SRBC  PFCs  determined.  No  effect on  antibody  responsiveness  to  TNP- 
Brucella or SRBC was observed. It was therefore possible to determine the effect 
of papain treatment of B cells on induction of tolerance. 
Effect of  Papain on Tolerance Susceptibility and the Relationship to Removal 
of Surface  IgD.  Adult  splenocytes  were  treated  with  0-100  /~g/ml  papain, CAMBIER,  VITETTA,  KETTMAN,  WETZEL,  AND  UHR 
TABLE I 
Relative Susceptibility of Surface Molecules  on Splenocytes  to 
Removal by Papain* 
Surface mole-  Number of 
cule  experiments 
Percent loss  after  papain treat- 
ment 
Average  Range 
IgD  5  92.8  87.4-98.6 
IgM  5  3.6  0.8-10.6 
H-2  3  0  0 
Ia  2  0  0 
Lyb2  2  2.1  0-4.2 
* Removal was assessed by treating radioiodinated cells  with papain 
and comparing  gel peaks of immunoprecipitates  from treated  and 
control cells  after SDS-PAGE. 
TABLE II 
Effect of Papain on Cell Metabolism 
111 
Parameter measured  Papain, 150/~g/ml  Control 
Protein synthesis*, cpm  1.7 x 106  1.6 x 105 
Immunoglobulin synthesis$  3.6 x 10  ~  2.3 × 105 
%Cr ~1 release§  45  44 
* Papain-treated and control cells were cultured for 24 h in complete medium 
containing [SH]leucine. After 24 h, cells were centrifuged,  lysed, and precipi- 
tated in 5% TCA acid. Values represent counts incorporated per 5 × 107 cells. 
See footnote*. Equal aliquots of the lysates were treated with RAMIg and an 
excess of GARIg. Precipitates were washed,  dissolved, and electrophoresed 
on SDS-PAGE. cpm in H-chain peaks were determined. Values represent 
counts from H-chain peaks of 5 × l0  T  cells. 
cpm in medium 
§  x  100 
cpm in cell pellet + cpm in medium 
washed,  and  either  radioiodinated  or cultured  for 24  h  with  varying doses of 
tolerogen  (TNP17HgG).  After cultivation,  cells were washed  and further incu- 
bated with TNP on either a  TD carrier (SRBC) or a TI carrier (Brucella). In the 
former case,  SRBC-primed  irradiated  splenocytes  were  added  as  a  source  of 
helper T  cells.  As increasing amounts of 8 were cleaved by papain  (Fig.  3, top 
panel), tolerance susceptibility of cells responsive to TNP on the TD carrier in- 
creased proportionately (Fig.  3,  lower left panel).  Susceptibility to tolerance of 
cells responsive to TNP on the TI carrier remained at a  constant high level re- 
gardless of the amount of IgD which had been cleaved (Fig. 3, lower right panel). 
Fig.  4  summarizes five experiments.  As can  be seen,  there  appears to be a 
direct relationship between the percentage of intact IgD remaining on the cells 
and  the  amount  of tolerogen required  to suppress  the response to TNP-SRBC 
(TD)  antigen  by  50%  (Ts0)  when  the  data  are  plotted  on  a  log-log  scale.  As 
described  above, removal of IgD has no effect on susceptibility to induction  of 
tolerance of TI antigen responsive cells. 
These results suggest that acquisition of IgD confers resistance to induction of 
tolerance upon TD antigen-reactive cells but not TI antigen-reactive cells. 
Regeneration  of IgD and Tolerance Susceptibility.  The possibility that pa- 112 
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Fie.  3.  SDS-polyacrylamide  electropherogram  (top  panel)  of cell  membrane-associated 
immunoglobulins from murine splenocytes treated with varying concentrations of papain. 
Lower left panel: dose responses to toterogen of papain-treated murine splenic B cells which 
are responsive to TD immunogen. Lower right panel: dose responses to tolerogen of papain- 
treated murine splenic B cells which are responsive to TI immunogen. Response to tolero- 
gen-free controls (direct PFC/106 viable recovered cells) were as follows: Lower left; 0 papain 
280, 10 ~g papain 168, 50 ~g papain 180, 100 ~g papain 169, Lower right; 0 papain 695, 10 ~g 
papain 690, 50 ~g papain 557, 100 ~g papain 654. 
pain  inactivated  an  IgD  ÷  cell  population  was  considered.  By  using  papain- 
treated splenocytes, the regeneration of IgD was evaluated as well as the loss of 
susceptibility to induction of tolerance. Adult spleen cells were treated with 100 
~g papain and a  portion of the cells radioiodinated.  The remaining cells were 
exposed to tolerogen immediately, or incubated for 24 h  without antigen.  Cells 
incubated for 24 h  without antigen were then either exposed to TNP,7 HgG to 
assess tolerance susceptibility or were radioiodinated, immunoprecipitated, and 
analyzed by SDS-PAGE to assess  IgD regeneration. The results are shown in 
Fig.  5.  Cells  exposed to TNP17HgG immediately after treatment with papain 
(Fig.  5 A) were rendered susceptible  to induction of tolerance as predicted by 
their loss of IgD (Fig. 5 C). Cells allowed to regenerate surface proteins for 24 h 
recovered approximately two-thirds of their IgD  (Fig.  5 B) and virtually all of CAMBIER,  VITETTA,  KETTMAN,  WETZEL,  AND  UHR  113 
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FIG.  4.  Relationship of percent IgD remaining on murine splenocytes after papain treat- 
ment to the tolerogen dose required to suppress plaque responses 50% ([Tso] [O]).  For TD re- 
sponse regression line, (-), r  =  0.98.  For TI regression line, (---), r  =  0.66.  Data points ob- 
tained from regeneration experiments by using cells before and after IgD regeneration (©) 
and controls for those points (©*)  were not used to construct regression line. 
their  resistance  to  induction  of tolerance  (Fig.  5 D).  When  the  percentage  of 
intact 8 was plotted against T5o, the two points fell near the regression line in 
Fig. 4, further supporting the concept of a relationship between cell surface IgD 
and susceptibility to tolerogen. 
Discussion 
The most striking observation to emerge from the present studies is that a cell 
surface molecule appears to regulate  the susceptibility of B  cells to tolerance 
induction.  Thus,  treatment  of splenic  B  cells  from  adult  mice  with  papain 
results in a marked increase in the susceptibility of those cells responsive to TD 
antigens to tolerance induction. Indeed, as a result of the proteolytic treatment, 
adult cells behaved like neonatal cells with regard to susceptibility to induction 
of tolerance in cells responsive to TD antigens.  The simplest interpretation  is 
that this alteration in adult cells results from cleavage of molecules from the cell 
surface. An alternative possibility, that the change in susceptibility to tolerance 
is  not related  to events  on the  cell  surface,  is regarded  as unlikely  since no 
evidence was obtained that treatment with papain under the defined conditions 
employed had significant effects on protein synthesis, cell viability, or immune 
responsiveness. Thus, treatment with papain did not affect incorporation by the 
cells  of [3H]leucine into  cellular  protein  or release  of Cr  5' from labeled cells. 
More pertinent,  when cells were cultured for 4 days in the presence of antigen, 
both  untreated  and  papain-treated  cells  responded  similarly  to  both  TNP- 
Brucella and TNP-SRBC. Taken together, the above results suggest that papain 
treatment  has no effect on the subsequent antibody responsiveness of B cells, 
probably  because  cell  surface  components  are  regenerated  in  vitro  rapidly 114  B-CELL  TOLERANCE 
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FIG.  5.  Relationship between the regeneration of IgD on papain-treated cells and toler- 
ance susceptibility. IgD cleavage and tolerance susceptibility were analyzed immediately 
after papain treatment (A, C) or after incubation for 24 h at 37°C to allow regeneration (B, 
D).  Responses of tolerogen-free controls (direct PFC/106  viable recovered cells) were as 
follows: in C, control = 127, papain treated =  119; in D, control =  206, papain treated = 242. 
enough to allow a  normal response.  Alternatively,  those components removed 
by papain may be unnecessary for subsequent functionP 
Treatment with papain under the conditions used in these experiments mark- 
edly affected only cell surface IgD and not five other known surface molecules. 
Thus, H-2, Ia, Lyb-2, and CR appeared unaffected by the treatment and IgM was 
reduced by a maximum of 10%. When the concentration of papain was varied, 
different proportions of cell surface IgD were cleaved from the cell. There was a 
striking  correlation  between  the  proportion  of IgD  cleaved  and  the  ease  of 
tolerance  induction in the TD antigen-reactive  cell pool.  Indeed,  if 90% of cell 
surface IgD was removed, then the dose of antigen that could tolerize to the 50% 
level was reduced 100-fold. Tolerance induction in TI responders was unaffected 
3 To clarify this point, the experimental protocol should be recalled (2). Since the tolerogen was 
added immediately after papain treatment, it is presumed that the assessment of the tolerance 
susceptibility of cells is occurring before the regeneration of molecules removed by papain. After 
24  h,  most surface molecules would be regenerated and  no  effect on  the subsequent immune 
response to SRBC is detectable, as mentioned. CAMBIER,  VITETTA, KETTMAN, WETZEL, AND  UHR  115 
by  papain  treatment  as  predicted by  the  previous  suggestion  (12) that  TI 
responders may bear no IgD. 
As can be seen in Fig. 4, the relationship between the radiolabeled surface IgD 
cleavage and susceptibility to tolerance induction appears to be a complex one. 
Thus, B cells are a  heterogeneous population with regard to their density of 
surface IgD, presence of  other isotypes on the same cell, and affinity of  receptors. 
Subpopulations may differ in their threshold requirements for tolerance induc- 
tion. Finally, the radioiodination procedure may not give precise relative quan- 
tifications of IgD on different cell populations. 
The possibility was considered that IgD-bearing cells were killed or perma- 
nently inactivated by treatment with papain even though the studies mentioned 
above of Cr  51 release and macromolecular  synthesis argued against this possibil- 
ity. Therefore, experiments were performed in which papain-treated cells were 
allowed to regenerate their receptors and the return of cell surface IgD and 
resistance to induction of tolerance were examined. Regeneration of 60-100% of 
normal amounts of surface IgD in 24 h suggested that cells previously denuded 
of  IgD were alive and metabolically active. Restoration of  the predicted degree of 
tolerance resistance (Figs. 4 and 5) provides additional correlative evidence that 
acquisition of  IgD results in loss of susceptibility to the induction of  tolerance. 
These results suggest, but do not prove, that IgD is the surface molecule that 
determines, in large measure, susceptibility to induction of tolerance of B cells 
responsive to  TD  antigens.  We  cannot  exclude the  possibility that  another 
unidentified molecule, which is removed (or altered) by papain and is subse- 
quently regenerated in the same manner as IgD, is responsible for the changes 
in tolerance susceptibility. Moreover, since we were unable to selectively re- 
move IgM from cells, while leaving IgD intact, it could be argued that the loss 
of either isotype might render cells more susceptible to the induction of toler- 
ance. A more definitive test of the role of IgD might be to determine the effect of 
both anti-/~ and anti-8 treatment of B cells on susceptibility to tolerance induc- 
tion. These experiments are in progress. 
Summary 
Under defined conditions, papain removes IgD from cells while leaving IgM, 
H-2,  Ia,  Lyb-2,  and complement receptor intact. The effect of such treatment 
with papain on the induction of tolerance in murine splenic B cells was deter- 
mined in an in vitro system. Treatment of the cells with papain has no effect on 
subsequent antibody responsiveness presumably because surface receptors re- 
generate before and during incubation with immunogen. Removal of increasing 
amounts of IgD results in increasing susceptibility of thymus-dependent  respon- 
sive cells to tolerance induction. The tolerance susceptibility of thymus-inde- 
pendent responsive cells, which we have previously suggested are immature 
cells that bear only IgM, is unaffected by cleavage of IgD. If cells are incubated 
for 24 h after treatment with papain, cell surface IgD and tolerance resistance 
return. These results indicate that a surface molecule affects susceptibility of B 
cells to induction of tolerance and suggest that this molecule may be IgD. 
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